2000;107:245 53. 21. Horlocker TT, Vandermeuelen E, Kopp SL, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Soci- ety of Regional Anesthesia and Pain Medicine evidence-based guidelines (fourth edition). Reg Anesth Pain Med. 2018;43:263 309. 22. De Santo LS, Romano G, Della Corte A, et al. Mitral mechanical re- placement in young rheumatic women: analysis of long-term survival, CLINICAL STATEMENTS AND GUIDELINES valve-related complications, and pregnancy outcomes over a 3707-pa- tient-year follow-up. J Thorac Cardiovasc Surg. 2005;130:13 9. 23. Ayad SW, Hassanein MM, Mohamed EA, et al. Maternal and fetal out- comes in pregnant women with a prosthetic mechanical heart valve. Clin Med Insights Cardiol. 2016;10:11 7. 24. Al-Lawati AAM, Venkitraman M, Al-Delaime T, et al. Pregnancy and me- chanical heart valves replacement; dilemma of anticoagulation. Eur J Car- diothorac Surg. 2002;22:223 7. 25. Hassouna A, Allam H. Limited dose warfarin throughout pregnancy in patients with mechanical heart valve prosthesis: a meta-analysis. Interact Cardiovasc Thorac Surg. 2014;18:797 806. 26. zkan M, akal B, Karakoyun S, et al. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low- dose, slow infusion of tissue-type plasminogen activator. Circulation. 2013;128:532 40. 27. McLintock C, McCowan LME, North RA. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. BJOG. 2009;116:1585 92. 28. Massel DR, Little SH. Antiplatelet and anticoagulation for patients with prosthetic heart valves. Cochrane Database Syst Rev. 2013;CD003464. 29. Eikelboom JW, Connolly SJ, Brueckmann M, et al. Dabigatran ver- sus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369:1206 14. 30. Lameijer H, Aalberts JJJ, van Veldhuisen DJ, et al. Efficacy and safety of di- rect oral anticoagulants during pregnancy; a systematic literature review. Thromb Res. 2018;169:123 7. 31. 